Schrödinger, Inc.
New York, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A computational platform company using physics-based simulations and AI to transform drug discovery and development.
OncologyImmunology
Technology Platform
A physics-based computational platform that integrates molecular simulation and machine learning to predict the chemical, biological, and pharmaceutical properties of molecules for drug discovery.
Opportunities
Expanding its internal pipeline into clinical stages could unlock tremendous value and validate its platform's predictive power.
Risk Factors
The risk that its computationally discovered drug candidates may fail in clinical trials, challenging the platform's ultimate value proposition.
Competitive Landscape
Faces competition from other computational chemistry software firms and a growing number of AI-first drug discovery companies, but its long-standing expertise and physics-based approach provide a distinct edge.